市場調査レポート
商品コード
1066955

キャピラリー電気泳動の世界市場 (2020年-2031年):製品タイプ・モード・用途・エンドユーザー別

Capillary Electrophoresis Market - A Global and Regional Analysis: Focus on Product Type, Mode, Application, End User - Analysis and Forecast, 2020-2031

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 177 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.31円
キャピラリー電気泳動の世界市場 (2020年-2031年):製品タイプ・モード・用途・エンドユーザー別
出版日: 2022年03月24日
発行: BIS Research Inc.
ページ情報: 英文 177 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のキャピラリー電気泳動の市場は予測期間中5.66%のCAGRで推移し、2031年には5億8,690万米ドルの規模に成長すると予測されています。

主要企業の戦略的イニシアティブ、さまざまな研究分野でのシーケンサーの導入の増加、個別化医療の導入の増加などの要因が同市場の成長を推進しています。また、大規模な新規診断用途のキャピラリー電気泳動に対する政府および民間の支援など、いくつかの機会も市場に成長をもたらしています。

当レポートでは、世界のキャピラリー電気泳動の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、製品タイプ・モード・用途・エンドユーザー・地域など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 市場

第2章 調査範囲

第3章 調査手法

第4章 市場概要

  • キャピラリー電気泳動の新たな応用
  • アドレサブル市場の規模・成長の可能性
  • COVID-19の影響
  • 競合情勢
  • 企業戦略
  • 事業戦略
  • 市場シェア分析 (企業別)
  • 成長シェア分析 (企業別)
  • 産業分析
  • 市場力学
  • 影響分析
  • 市場促進要因
  • 市場抑制要因
  • 市場機会

第5章 世界のキャピラリー電気泳動市場:製品タイプ別

  • 機器
  • 消耗品
  • ソフトウェア

第6章 世界のキャピラリー電気泳動市場:モード別

  • キャピラリーゲル電気泳動 (CGE)
    • キャピラリーゾーン電気泳動 (CZE)
    • キャピラリーエレクトロクロマトグラフィー (CEC)
    • その他

第7章 世界のキャピラリー電気泳動市場:用途別

  • 核酸分析
  • タンパク質分析

第8章 世界のキャピラリー電気泳動市場:エンドユーザー別

  • 学術・研究機関
  • 臨床ラボ
  • 製薬・バイオテクノロジー企業
  • その他

第9章 世界のキャピラリー電気泳動市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • その他の地域

第10章 市場:競合ベンチマーキング・企業プロファイル

  • 概要
  • QIAGEN
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Bio-Techne
  • PerkinElmer Inc.
  • Merck KGaA
  • Promega Corporation
  • Shimadzu Corporation
  • Helena Laboratories
  • BiOptic Inc.
  • LABGENE Scientific SA
  • Hitachi Ltd.
  • Teledyne Technologies Incorporated
図表

List of Figures

  • Figure 1: Annual NIH Funding in Human Genomics Research, $Billion, FY2013-FY2020
  • Figure 2: Global Capillary Electrophoresis Market Dynamics
  • Figure 3: Share of Key Market Strategies and Developments, February 2018-December 2021
  • Figure 4: Global Capillary Electrophoresis Market Snapshot, $Million, 2020-2031
  • Figure 5: Global Capillary Electrophoresis Market (by Product Type), $Million, 2020 Vs. 2031
  • Figure 6: Global Capillary Electrophoresis Market (by Mode), $Million, 2020 Vs. 2031
  • Figure 7: Global Capillary Electrophoresis Market (by Application), $Million, 2020 Vs. 2031
  • Figure 8: Global Capillary Electrophoresis Market (by End User), $Million, 2020 Vs. 2031
  • Figure 9: Global Capillary Electrophoresis Market (by Region), $Million, 2020 Vs. 2031
  • Figure 10: Global Capillary Electrophoresis Market: Segmentation
  • Figure 11: Global Capillary Electrophoresis Market Research Methodology
  • Figure 12: Global Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 13: Pre-COVID-19 and Post-COVID-19 Scenario of Global Capillary Electrophoresis Market, 2019-2026
  • Figure 14: Impact of COVID-19 on Capillary Electrophoresis Market
  • Figure 15: Share of Key Developments and Strategies, January 2018-December 2021
  • Figure 16: Share of Synergistic Activities (by Company), September 2020-November 2021
  • Figure 17: Share of Acquisition (by Company), March 2018-December 2021
  • Figure 18: Share of Business Expansion (by Company), February 2018-June 2021
  • Figure 19: Share of Product Launches (by Company), July 2018-September 2021
  • Figure 20: Market Share Analysis for Global Capillary Electrophoresis Market, $Million, 2019 and 2020
  • Figure 21: Growth Share Analysis of Global Capillary Electrophoresis Market (by Company), 2019-2020
  • Figure 22: Responsibilities of the National Medical Products Administration (NMPA)
  • Figure 23: Global Capillary Electrophoresis Market Dynamics
  • Figure 24: Global Capillary Electrophoresis Market (by Product Type), $Million, 2020 and 2031
  • Figure 25: Global Capillary Electrophoresis Market (Instruments), $Million, 2020-2031
  • Figure 26: Global Capillary Electrophoresis Market (Instruments), Thousand Units, 2021-2031
  • Figure 27: Global Capillary Electrophoresis Market (Consumables), $Million, 2020-2031
  • Figure 28: Global Capillary Electrophoresis Market (Kits), $Million, 2020-2031
  • Figure 29: Global Capillary Electrophoresis Market (Kits), Thousand Units, 2021-2031
  • Figure 30: Global Capillary Electrophoresis Market (Reagents), $Million, 2020-2031
  • Figure 31: Global Capillary Electrophoresis Market (Other Consumables), $Million, 2020-2031
  • Figure 32: Global Capillary Electrophoresis Market (Software), $Million, 2020-2031
  • Figure 33: Share of Global Capillary Electrophoresis Market (by Mode), $Million, 2020 and 2031
  • Figure 34: Global Capillary Electrophoresis Market (Capillary Gel Electrophoresis), $Million, 2020-2031
  • Figure 35: Global Capillary Electrophoresis Market (Capillary Zone Electrophoresis), $Million, 2020-2031
  • Figure 36: Global Capillary Electrophoresis Market (Capillary Electro Chromatography), $Million, 2020-2031
  • Figure 37: Global Capillary Electrophoresis Market (Other Mode), $Million, 2020-2031
  • Figure 38: Share of Global Capillary Electrophoresis Market (by Application), $Million, 2020 and 2031
  • Figure 39: Global Capillary Electrophoresis Market (Nucleic Acid Analysis), $Million, 2021-2031
  • Figure 40: Global Capillary Electrophoresis Market (DNA Fragment Analysis), $Million, 2020-2031
  • Figure 41: Global Capillary Electrophoresis Market (SNP Genotyping), $Million, 2020-2031
  • Figure 42: Global Capillary Electrophoresis Market (Gene Editing), $Million, 2020-2031
  • Figure 43: Global Capillary Electrophoresis Market (Others), $Million, 2021-2031
  • Figure 44: Global Capillary Electrophoresis Market (RNA/mRNA Analysis), $Million, 2021-2031
  • Figure 45: Global Capillary Electrophoresis Market (Protein Analysis), $Million, 2020-2031
  • Figure 46: Share of Global Capillary Electrophoresis Market (by End User), $Million, 2020 and 2031
  • Figure 47: Global Capillary Electrophoresis Market (Academic and Research Institutions), $Million, 2020-2031
  • Figure 48: Global Capillary Electrophoresis Market (Clinical Laboratories), $Million, 2020-2031
  • Figure 49: Global Capillary Electrophoresis Market (Pharmaceutical and Biotechnology Companies), $Million, 2020-2031
  • Figure 50: Global Capillary Electrophoresis Market (Other End User), $Million, 2020-2031
  • Figure 51: Global Capillary Electrophoresis Market (by Region), $Million, 2020-2031
  • Figure 52: Share of North America Capillary Electrophoresis Market Revenue (by Country), $Million, 2020 and 2031
  • Figure 53: North America: Market Dynamics
  • Figure 54: U.S. Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 55: Canada Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 56: Europe Capillary Electrophoresis Market (by Country), $Million, 2020 and 2031
  • Figure 57: Europe: Market Dynamics
  • Figure 58: Germany Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 59: U.K. Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 60: France Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 61: Italy Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 62: Spain Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 63: Switzerland Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 64: Rest-of-Europe Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 65: APAC: Market Dynamics
  • Figure 66: Asia-Pacific Capillary Electrophoresis Market (by Country), $Million, 2020 and 2031
  • Figure 67: China Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 68: India Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 69: Japan Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 70: Australia Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 71: South Korea Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 72: Rest-of-Asia-Pacific Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 73: LATAM: Market Dynamics
  • Figure 74: Latin America Capillary Electrophoresis Market (by Country), $Million 2020-2031,
  • Figure 75: Brazil Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 76: Mexico Capillary Electrophoresis Market, Million, 2020-2031
  • Figure 77: Rest-of-Latin America Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 78: Rest-of-the-World Capillary Electrophoresis Market, $Million, 2020-2031
  • Figure 79: Share of Key Company Profiles
  • Figure 80: QIAGEN: Overall Product Portfolio
  • Figure 81: QIAGEN: Overall Financials, $Million, 2018-2020
  • Figure 82: QIAGEN: Revenue (by Segment), $Million, 2018-2020
  • Figure 83: QIAGEN: Revenue (by Region), $Million, 2018-2020
  • Figure 84: QIAGEN: R&D Expenditure, $Million, 2018-2020
  • Figure 85: QIAGEN: SWOT Analysis
  • Figure 86: Thermo Fisher Scientific Inc.: Overall Product Portfolio
  • Figure 87: Thermo Fisher Scientific Inc.: Overall Financials, $Million, 2018-2020
  • Figure 88: Thermo Fisher Scientific Inc.: Revenue (by Segment), $Million, 2018-2020
  • Figure 89: Thermo Fisher Scientific Inc.: Revenue (by Region), 2018-2020
  • Figure 90: Thermo Fisher Scientific Inc.: R&D Expenditure, $Million, 2018-2020
  • Figure 91: Thermo Fisher Scientific Inc.: SWOT Analysis
  • Figure 92: Agilent Technologies, Inc.: Overall Product Portfolio
  • Figure 93: Agilent Technologies, Inc.: Overall Financials, 2018-2020
  • Figure 94: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
  • Figure 95: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
  • Figure 96: Agilent Technologies, Inc.: R&D Expenditure, 2018-2020
  • Figure 97: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 98: Bio-Rad Laboratories, Inc.: Overall Product Portfolio
  • Figure 99: Bio-Rad Laboratories, Inc.: Overall Financials, 2018-2020
  • Figure 100: Bio-Rad Laboratories, Inc.: Revenue (by Segment), 2018-2020
  • Figure 101: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2018-2020
  • Figure 102: Bio-Rad Laboratories, Inc.: R&D Expenditure, 2018-2020
  • Figure 103: Bio-Rad Laboratories, Inc.: SWOT Analysis
  • Figure 104: Danaher: Overall Product Portfolio
  • Figure 105: Danaher: Overall Financials, 2018-2020
  • Figure 106: Danaher: Revenue (by Segment), 2018-2020
  • Figure 107: Danaher: Revenue (by Region), 2018-2020
  • Figure 108: Danaher: R&D Expenditure, 2018-2020
  • Figure 109: Danaher: SWOT Analysis
  • Figure 110: Bio-Techne: Product Portfolio
  • Figure 111: Bio-Techne: Overall Financials, 2018-2020
  • Figure 112: Bio-Techne Revenue (by Segment), 2018-2020
  • Figure 113: Bio-Techne.: Revenue (by Region), 2018-2020
  • Figure 114: Bio-Techne: R&D Expenditure, 2018-2020
  • Figure 115: Bio-Techne: SWOT Analysis
  • Figure 116: PerkinElmer Inc.: Product Portfolio
  • Figure 117: PerkinElmer Inc.: Overall Financials, 2018-2020
  • Figure 118: PerkinElmer Inc.: Revenue (by Segment), 2018-2020
  • Figure 119: PerkinElmer Inc: Revenue (by Region), 2018-2020
  • Figure 120: PerkinElmer Inc.: R&D Expenditure, 2018-2020
  • Figure 121: PerkinElmer Inc.: SWOT Analysis
  • Figure 122: Merck KGaA: Product Portfolio
  • Figure 123: Merck KGaA: Overall Financials, 2018-2020
  • Figure 124: Merck KGaA: Revenue (by Segment), 2018-2020
  • Figure 125: Merck KGaA: Revenue (by Region), 2018-2020
  • Figure 126: Merck KgaA: R&D Expenditure, 2018-2020
  • Figure 127: Merck KGaA: SWOT Analysis
  • Figure 128: Promega Corporation.: Product Portfolio
  • Figure 129: Promega Corporation: SWOT Analysis
  • Figure 130: Shimadzu Corporation: Product Portfolio
  • Figure 131: Shimadzu Corporation: Overall Financials, 2018-2020
  • Figure 132: Shimadzu Corporation: Revenue (by Segment), 2018-2020
  • Figure 133: Shimadzu Corporation: Revenue (by Region), 2018-2020
  • Figure 134: Shimadzu Corporation: R&D Expenditure, 2018-2020
  • Figure 135: Shimadzu Corporation: SWOT Analysis
  • Figure 136: Helena Laboratories: Product Portfolio
  • Figure 137: Helena Laboratories: SWOT Analysis
  • Figure 138: BiOptic Inc.: Product Portfolio
  • Figure 139: BiOptic Inc.: SWOT Analysis
  • Figure 140: LABGENE Scientific SA: Product Portfolio
  • Figure 141: LABGENE Scientific SA: SWOT Analysis
  • Figure 142: Hitachi Ltd.: Product Portfolio
  • Figure 143: Hitachi Ltd.: Overall Financials, 2018-2020
  • Figure 144: Hitachi Ltd.: Revenue (by Segment), 2018-2020
  • Figure 145: Hitachi Ltd.: Revenue (by Region), 2018-2020
  • Figure 146: Hitachi Ltd.: R&D Expenditure, 2018-2020
  • Figure 147: Hitachi Ltd.: SWOT Analysis
  • Figure 148: Teledyne Technologies Incorporated: Product Portfolio
  • Figure 149: Teledyne Technologies Incorporated: Overall Financials, 2018-2020
  • Figure 150: Teledyne Technologies Incorporated: Revenue (by Segment), 2018-2020
  • Figure 151: Teledyne Technologies Incorporated: Revenue (by Region), 2018-2020
  • Figure 152: Teledyne Technologies Incorporated: SWOT Analysis

List of Tables

  • Table 1: COVID-19 Impact on Global Capillary Electrophoresis Market
  • Table 2: Products Launched by Various Manufacturers for Capillary Electrophoresis Research
  • Table 3: Stratergic Initative by Key Market Players
  • Table 4: Adoption of Sequencing in Various Research Fields
  • Table 5: Adoption of Personalized Medicine
  • Table 6: Cost of Capillary Electrophoresis Products
  • Table 7: Government and Private Support for Capillary Electrophoresis products
  • Table 8: Novel Diagnostic Applications
  • Table 9: List of Instruments
  • Table 10: List of Consumables
  • Table 11: List of Software
目次
Product Code: BHP1173SA

“Global Capillary Electrophoresis Market to Reach $586.9 Million by 2031.”

Market Report Coverage - Capillary Electrophoresis

Market Segmentation

  • By Product Type - Instrument, Consumables, and Software
  • By Mode - Capillary Gel Electrophoresis (CGE), Capillary Zone Electrophoresis (CZE), Capillary Electro Chromatography (CEC), and Other Mode
  • By Application - Nucleic Acid Analysis and Protein Analysis
  • By End User - Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User

Regional Segmentation

  • North America: U.S., Canada
  • Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe
  • Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific
  • Latin America: Brazil, Mexico, and Rest-of-Latin America
  • Rest-of-the-World

Market Growth Drivers

  • Strategic Initiatives by Key Market Players
  • Increasing Adoption of Sequencing in Various Research Fields
  • Increase in Adoption of Personalized Medicine

Market Challenges

  • Lack of Infrastructure and Expertise
  • High Capital Requirement Hampering the Expansion of Global Reach
  • Uncertain Reimbursement Scenario

Market Opportunities

  • Government and Private Support for Capillary Electrophoresis on a Large Scale
  • Novel Diagnostic Applications

Key Companies Profiled

QIAGEN, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher, Bio-Techne, PerkinElmer Inc., Merck KGaA, Promega Corporation, Shimadzu Corporation, Helena Laboratories, BiOptic Inc., LABGENE Scientific SA, Hitachi Ltd., Teledyne Technologies Incorporated.

Key Questions Answered in this Report:

  • How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
    • Product type (instrument, consumables, and software)
    • Mode (capillary gel electrophoresis, capillary zone electrophoresis, and capillary electro chromatography)
    • Applications (nucleic acid analysis and protein analysis)
    • End user (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end users)
    • Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
  • What are the major market drivers, challenges, and opportunities in the global capillary electrophoresis market?
  • What are the underlying structures resulting in the emerging trends within the global capillary electrophoresis market?
  • How is each segment of the global capillary electrophoresis market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
  • What are the key developmental strategies implemented by the major players to sustain in the competitive market?
  • What are the key regulatory implications in developed and developing regions for capillary electrophoresis?
  • Who are the leading players with significant offerings to the global capillary electrophoresis market? What is the current market dominance for each of these leading players?
  • What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which capillary electrophoresis product type is anticipated to have the most promising growth?
  • What are the key applications in the global capillary electrophoresis market? What are the major segments of these applications? What technologies are dominating these application segments?
  • What are the major technologies that are employed in the global capillary electrophoresis market? Which is the dominating technology?
  • Who are the primary end users of the global capillary electrophoresis market? Which is the fastest-growing end-use segment in the global capillary electrophoresis market?
  • Who are the key manufacturers in the global capillary electrophoresis market, and what are their contributions? Also, what is the growth potential of each major capillary electrophoresis manufacturer?
  • What is the scope of the global capillary electrophoresis market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which capillary electrophoresis application and end user dominate these regions?
  • What are the emerging trends in the global capillary electrophoresis market? How are these trends revolutionizing the diagnostic procedure?
  • Which companies are anticipated to be highly disruptive in the future and why?
  • What are the regulatory procedures that are required to unify the approval process for emerging capillary electrophoresis? How will these enhance the reimbursement scenario?
  • What are the gaps in regularizing optimum capillary electrophoresis adoption in regular healthcare routines? How are these gaps being tackled?

Market Overview

Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy and is broadly used for nucleic acid analysis and protein analysis applications.

Our healthcare experts have found the capillary electrophoresis market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031.

Factors fueling the growth of the market include strategic initiatives by key market players and increasing adoption of sequencing in various research fields increase in adoption of personalized medicine; despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. Lack of infrastructure and expertise high capital requirement hampering the expansion of global reach uncertain reimbursement scenario further, some of the opportunities, such as government and private support for capillary electrophoresis on large-scale novel diagnostic applications, provide growth to the market.

Within the research report, the market has been segmented on the basis of product type, mode, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the global level has created a buzz among companies to invest in advanced technologies such as molecular diagnostics.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.

Table of Contents

1 Markets

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion

2 Scope of the Study

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 Data Source
    • 3.1.1 Primary Data Source
      • 3.1.1.1 Primary Research Methodology
    • 3.1.2 Secondary Data Sources
      • 3.1.2.1 Open Sources
  • 3.2 Market Estimation Model
    • 3.2.1 Criteria for Company Profiling

4 Market Overview

  • 4.1 Emerging Applications of Capillary Electrophoresis
  • 4.2 Addressable Market Size and Growth Potential
  • 4.3 COVID-19 Impact on Global Capillary Electrophoresis Market
    • 4.3.1 Impact on Market Size
  • 4.4 Competitive Landscape
  • 4.5 Corporate Strategies
    • 4.5.1 Synergistic Activities
    • 4.5.2 Acquisitions
    • 4.5.3 Business Expansion
  • 4.6 Business Strategies
    • 4.6.1 Product Launches
  • 4.7 Market Share Analysis (by Company)
  • 4.8 Growth Share Analysis (by Company)
  • 4.9 Industry Analysis
    • 4.9.1 Legal Requirements and Framework in the U.S.
    • 4.9.2 FDA Regulations
    • 4.9.3 Legal Requirements and Framework in Europe
      • 4.9.3.1 U.K.
      • 4.9.3.2 Germany
  • 4.1 Legal Requirements and Framework in Asia-Pacific
      • 4.10.1.1 China
      • 4.10.1.2 Japan
        • 4.10.1.2.1 Pharmaceuticals and Medical Devices Agency (PMDA)
  • 4.11 Market Dynamics
  • 4.12 Impact Analysis
  • 4.13 Market Drivers
    • 4.13.1 Strategic Initiatives by Key Market Players
    • 4.13.2 Increasing Adoption of Sequencing in Various Research Fields
    • 4.13.3 Increase in Adoption of Personalized Medicine
  • 4.14 Market Restraints
    • 4.14.1 Lack of Infrastructure and Expertise
    • 4.14.2 High Capital Requirement Hampering the Expansion of Global Reach
    • 4.14.3 Uncertain Reimbursement Scenario
  • 4.15 Opportunities
    • 4.15.1 Government and Private Support for Capillary Electrophoresis on a Large Scale
    • 4.15.2 Novel Diagnostic Applications

5 Global Capillary Electrophoresis Market, by Products Type, $Million, 2020-2031

  • 5.1 Overview
    • 5.1.1 Instrument
    • 5.1.2 Consumables
      • 5.1.2.1 Kits
      • 5.1.2.2 Reagents
      • 5.1.2.3 Other Consumables
    • 5.1.3 Software

6 Global Capillary Electrophoresis Market, by Mode, $Million, 2020-2031

  • 6.1 Overview
  • 6.2 Capillary Gel Electrophoresis (CGE)
    • 6.2.1 Capillary Zone Electrophoresis (CZE)
    • 6.2.2 Capillary Electro Chromatography (CEC)
    • 6.2.3 Other Mode

7 Global Capillary Electrophoresis Market, by Application, $Million, 2020-2031

  • 7.1 Overview
    • 7.1.1 Nucleic Acid Analysis
      • 7.1.1.1 DNA Fragment Analysis
        • 7.1.1.1.1 SNP Genotyping
        • 7.1.1.1.2 Gene Editing
        • 7.1.1.1.3 Others
      • 7.1.1.2 RNA/mRNA Analysis
    • 7.1.2 Protein Analysis

8 Global Capillary Electrophoresis Market, by End User, $Million, 2020-2031

  • 8.1 Overview
    • 8.1.1 Academic and Research Institutions
    • 8.1.2 Clinical Laboratories
    • 8.1.3 Pharmaceutical and Biotechnology Companies
    • 8.1.4 Other End User

9 Global Capillary Electrophoresis Market, by Region, $Million, 2020-2031

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K.
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Switzerland
    • 9.3.7 Rest-of-Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest-of-Asia-Pacific
  • 9.5 Latin America (LATAM)
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest-of-Latin America
  • 9.6 Rest-of-the-World (RoW)

10 Markets - Competitive Benchmarking & Company Profiles

  • 10.1 Overview
  • 10.2 QIAGEN
    • 10.2.1 Company Overview
    • 10.2.2 Role of QIAGEN in the Global Capillary Electrophoresis Market
    • 10.2.3 Key Customers of the Company
    • 10.2.4 Key Competitors of the Company
    • 10.2.5 Financials
    • 10.2.6 Key Insights About Financial Health of the Company
    • 10.2.7 SWOT Analysis
  • 10.3 Thermo Fisher Scientific Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Role of Thermo Fisher Scientific Inc. in the Global Capillary Electrophoresis Market
    • 10.3.3 Key Customers of the Company
    • 10.3.4 Key Competitors of the Company
    • 10.3.5 Financials
    • 10.3.6 Key Insights About Financial Health of the Company
    • 10.3.7 SWOT Analysis
  • 10.4 Agilent Technologies, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Role of Agilent Technologies, Inc. in the Global Capillary Electrophoresis Market
    • 10.4.3 Key Customers of the Company
    • 10.4.4 Key Competitors of the Company
    • 10.4.5 Financials
    • 10.4.6 Key Insights About Financial of the Company
    • 10.4.7 SWOT Analysis
  • 10.5 Bio-Rad Laboratories, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Role of Bio-Rad Laboratories, Inc. in the Global Capillary Electrophoresis Market
    • 10.5.3 Key Customers of the Company
    • 10.5.4 Key Competitors of the Company
    • 10.5.5 Financials
    • 10.5.6 Key Insights About Financial Health of the Company
    • 10.5.7 SWOT Analysis
  • 10.6 Danaher
    • 10.6.1 Company Overview
    • 10.6.2 Role of Danaher in the Global Capillary Electrophoresis Market
    • 10.6.3 Key Customers of the Company
    • 10.6.4 Key Competitors of the Company
    • 10.6.5 Financials
    • 10.6.6 Key Insights About Financial Health of the Company
    • 10.6.7 SWOT Analysis
  • 10.7 Bio-Techne
    • 10.7.1 Company Overview
    • 10.7.2 Role of Bio-Techne in the Global Capillary Electrophoresis Market
    • 10.7.3 Key Customers of the Company
    • 10.7.4 Key Competitors of the Company
    • 10.7.5 Financials
    • 10.7.6 Key Insights About Financial Health of the Company
    • 10.7.7 SWOT Analysis
  • 10.8 PerkinElmer Inc.
    • 10.8.1 Company Overview
    • 10.8.2 Role of PerkinElmer Inc. in the Global Capillary Electrophoresis Market
    • 10.8.3 Key Customers of the Company
    • 10.8.4 Key Competitors of the Company
    • 10.8.5 Financials
    • 10.8.6 Key Insights About Financial Health of the Company
    • 10.8.7 SWOT Analysis
  • 10.9 Merck KGaA
    • 10.9.1 Company Overview
    • 10.9.2 Role of Merck KGaA in the Global Capillary Electrophoresis Market
    • 10.9.3 20.3 Key Customers of the Company
    • 10.9.4 Key Competitors of the Company
    • 10.9.5 Financials
    • 10.9.6 Key Insights About Financial Health of the Company
    • 10.9.7 SWOT Analysis
  • 10.1 Promega Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Role of Promega Corporation in the Global Capillary Electrophoresis Market
    • 10.10.3 Key Customers of the Company
    • 10.10.4 Key Competitors of the Company
    • 10.10.5 SWOT Analysis
  • 10.11 Shimadzu Corporation
    • 10.11.1 Company Overview
    • 10.11.2 Role of Shimadzu Corporation in the Global Capillary Electrophoresis Market
    • 10.11.3 Key Customers of the Company
    • 10.11.4 Key Competitors of the Company
    • 10.11.5 Financials
    • 10.11.6 Key Insights About Financial Health of the Company
    • 10.11.7 SWOT Analysis
  • 10.12 Helena Laboratories
    • 10.12.1 Company Overview
    • 10.12.2 Role of Helena Laboratories in the Global Capillary Electrophoresis Market
    • 10.12.3 Key Customers of the Company
    • 10.12.4 Key Competitors of the Company
    • 10.12.5 SWOT Analysis
  • 10.13 BiOptic Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Role of BiOptic Inc. in the Global Capillary Electrophoresis Market
    • 10.13.3 Key Customers of the Company
    • 10.13.4 Key Competitors of the Company
    • 10.13.5 SWOT Analysis
  • 10.14 LABGENE Scientific SA
    • 10.14.1 Company Overview
    • 10.14.2 Role of LABGENE Scientific SA in the Global Capillary Electrophoresis Market
    • 10.14.3 Key Customers of the Company
    • 10.14.4 Key Competitors of the Company
    • 10.14.5 SWOT Analysis
  • 10.15 Hitachi Ltd.
    • 10.15.1 Company Overview
    • 10.15.2 Role of Hitachi Ltd. in the Global Capillary Electrophoresis Market
    • 10.15.3 Key Customers of the Company
    • 10.15.4 Key Competitors of the Company
    • 10.15.5 Financials
    • 10.15.6 Key Insights About Financial Health of the Company
    • 10.15.7 SWOT Analysis
  • 10.16 Teledyne Technologies Incorporated
    • 10.16.1 Company Overview
    • 10.16.2 Role of Teledyne Technologies Incorporated in the Global Capillary Electrophoresis Market
    • 10.16.3 Key Customers of the Company
    • 10.16.4 Key Competitors of the Company
    • 10.16.5 Financials
    • 10.16.6 SWOT Analysis